The Menopause Metabolic Protocol: Targeting the Three Root Causes
How MOTS-c, 5-Amino-1MQ, SS-31, and BPC-157 address inflammation, insulin resistance, and ATP shortage
Key Findings
- 1Menopause triggers metabolic dysfunction through three overlapping root causes
- 2MOTS-c targets mitochondrial signaling and may mimic exercise at the cellular level
- 35-Amino-1MQ inhibits the NNMT enzyme, supporting NAD+ recycling and metabolic flexibility
- 4SS-31 (Elamipretide) directly targets mitochondrial membrane integrity and ATP production
- 5BPC-157 addresses the inflammatory cascade that accelerates metabolic aging
Why Menopause Breaks Metabolism
Menopause doesn't just reduce estrogen — it disrupts the entire metabolic system through three interconnected root causes. Understanding these is the key to building an effective protocol.
The Three Root Causes
- Inflammation — estrogen decline removes a major anti-inflammatory signal, leading to chronic systemic inflammation (elevated CRP, joint pain, brain fog)
- Insulin Resistance — metabolic signaling shifts toward fat storage, especially visceral fat; glucose tolerance decreases; energy crashes become frequent
- ATP Shortage — mitochondrial efficiency declines sharply; cellular energy production drops; recovery time increases; exercise tolerance falls
Most interventions target only ONE root cause. This protocol addresses all three simultaneously — which is why it produces compound (no pun intended) results.
The Four-Compound Stack
MOTS-c
ExperimentalDose
5mg, three times per week
Frequency
Mon / Wed / Fri
Route
Subcutaneous injection
Mechanism: Mitochondrial-derived peptide that activates AMPK signaling — the same pathway triggered by exercise. Improves metabolic flexibility, glucose uptake, and fat oxidation.
5-Amino-1MQ
ExperimentalDose
50mg daily
Frequency
Once daily, morning
Route
Oral capsule
Mechanism: NNMT enzyme inhibitor. Blocks the enzyme that depletes NAD+ and promotes visceral fat storage. Supports metabolic efficiency and cellular energy recycling.
SS-31 (Elamipretide)
ClinicalDose
40mg daily
Frequency
Once daily
Route
Subcutaneous injection
Mechanism: Targets cardiolipin in the inner mitochondrial membrane, stabilizing the electron transport chain and restoring ATP production. One of the few compounds with direct mitochondrial access.
BPC-157
ClinicalDose
500mcg daily
Frequency
Once daily, morning
Route
Subcutaneous injection only (oral is ineffective)
Mechanism: Anti-inflammatory peptide that modulates TNF-alpha, IL-6, and nitric oxide pathways. Addresses the chronic inflammatory cascade triggered by estrogen decline.
Protocol Timeline
| Weeks 1-2 | Start BPC-157 and 5-Amino-1MQ only. Half-dose MOTS-c (2.5mg 2x/week) to assess tolerance. |
| Weeks 3-8 | Full protocol: all four compounds at target doses. Monitor energy, sleep quality, body composition. |
| Weeks 9-12 | Continue BPC-157 and 5-Amino-1MQ. Cycle MOTS-c to 2x/week. Assess SS-31 response. |
| Bloodwork | Baseline + Week 8: fasting insulin, fasting glucose, CRP, IGF-1, lipid panel, CBC |
| Monthly cost | $200-350 depending on vendor and dosing |
Track This Protocol
Log doses, monitor interactions, and optimize your stack with AI tools.
Open DoseCraftSource Compounds
Pharma-grade, third-party tested. Our preferred vendor for the DoseCraft community.
Visit Apex PeptidesWhy This Combination Works
Each compound targets a different root cause, but they also create synergistic effects. MOTS-c and SS-31 both improve mitochondrial function through different mechanisms (AMPK activation vs. membrane stabilization). 5-Amino-1MQ supports the NAD+ pool that both mitochondrial peptides depend on. And BPC-157 reduces the inflammatory load that accelerates all three root causes. The result is a protocol where each compound amplifies the others.
This article is for educational purposes only. This is not a prescription. Consult a licensed healthcare professional before starting any peptide protocol, especially during menopause when hormonal changes affect drug metabolism.
Put this research into action
Track your protocol with precision tools. Source pharma-grade compounds from a trusted vendor.
Track in DoseCraft
Build this protocol in 60 seconds. AI-powered dose logging, half-life tracking, and interaction checks.
Open Protocol BuilderGet the Compounds
Pharma-grade, third-party tested peptides from our preferred vendor. Trusted by the community.
Visit Apex PeptidesNot medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol. Affiliate links may be present — we only recommend vendors we trust.